GlaxoSmithKline S.A.E (EGX:BIOC)

GlaxoSmithKline S.A.E Ratios and Metrics

Market cap in millions EGP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 1, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,116	3,007	2,969	3,187	2,579	1,416
Market Cap Growth	65.57%	1.27%	-6.84%	23.57%	82.08%	-14.17%
Enterprise Value	6,039	3,430	2,758	2,079	2,840	1,603
Last Close Price	61.26	35.43	34.08	33.07	25.86	14.01
PE Ratio	52.29	17.28	49.11	4.33	16.68	50.35
PS Ratio	1.37	1.00	1.33	1.75	1.42	0.71
PB Ratio	2.51	1.51	1.51	1.84	1.90	1.17
P/TBV Ratio	2.52	1.51	1.51	2.00	2.31	1.45
P/FCF Ratio	-	-	13.18	3.23	16.49	-
P/OCF Ratio	-	-	9.82	3.08	13.42	-
EV/Sales Ratio	1.61	1.15	1.23	1.14	1.57	0.81
EV/EBITDA Ratio	26.67	7.36	5.71	42.79	10.20	6.94
EV/EBIT Ratio	35.93	8.05	6.15	135.68	11.73	7.92
EV/FCF Ratio	-30.47	-	12.25	2.11	18.15	-
Debt / Equity Ratio	0.62	0.06	0.05	0.04	0.13	0.12
Debt / EBITDA Ratio	5.59	0.25	0.20	1.07	0.60	0.63
Debt / FCF Ratio	-	-	0.43	0.07	1.15	-
Net Debt / Equity Ratio	0.45	0.02	-0.37	-0.30	0.08	0.10
Net Debt / EBITDA Ratio	4.32	0.09	-1.52	-10.62	0.38	0.54
Net Debt / FCF Ratio	-4.65	-0.08	-3.25	-0.52	0.68	-2.25
Asset Turnover	0.91	0.83	0.66	0.65	0.80	0.89
Inventory Turnover	2.35	2.51	2.46	2.57	2.31	3.15
Quick Ratio	0.41	0.47	1.01	0.95	0.73	0.58
Current Ratio	1.53	1.82	1.88	1.76	1.53	1.44
Return on Equity (ROE)	4.97%	8.79%	3.27%	-7.38%	12.03%	2.32%
Return on Assets (ROA)	2.55%	7.38%	8.32%	0.34%	6.66%	5.62%
Return on Invested Capital (ROIC)	3.32%	13.37%	18.54%	1.15%	14.91%	4.89%
Return on Capital Employed (ROCE)	8.00%	20.50%	22.10%	0.90%	17.10%	16.50%
Earnings Yield	1.92%	5.79%	2.04%	23.08%	6.00%	1.99%
FCF Yield	-3.87%	-17.58%	7.58%	30.98%	6.07%	-3.87%
Dividend Yield	1.63%	-	2.20%	-	2.90%	-
Payout Ratio	14.36%	40.05%	217.67%	15.10%	3.61%	19.84%
Total Shareholder Return	0.94%	-	2.20%	-	2.90%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.